Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander H Glassman

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|June 29, 2002
Clinical management of cardiovascular risks during treatment with psychotropic drugsAlexander H Glassman
Dialogues in Clinical Neuroscience|May 18, 2007
Depression and cardiovascular comorbidityAlexander H Glassman
The Journal of Clinical Psychiatry|August 19, 2005
Schizophrenia, antipsychotic drugs, and cardiovascular diseaseAlexander H Glassman
Cleveland Clinic Journal of Medicine|July 13, 2010
The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raisedJ Thomas Bigger, Alexander H Glassman
Archives of General Psychiatry|September 9, 2009
Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participantsAlexander H Glassman, J Thomas Bigger, Michael Gaffney
The Journal of Clinical Psychiatry|March 16, 2005
Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarctionChristopher M O'Connor, Alexander H Glassman, David J Harrison
Archives of General Psychiatry|September 5, 2007
Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvementAlexander H Glassman, J Thomas Bigger, Michael Gaffney, et al.
The American Journal of Psychiatry|October 3, 2002
A randomized trial of sertraline as a cessation aid for smokers with a history of major depressionLirio S Covey, Alexander H Glassman, Fay Stetner, et al.
The Journal of Clinical Psychiatry|June 29, 2002
Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatmentHerbert Y Meltzer, Michael Davidson, Alexander H Glassman, et al.
Archives of General Psychiatry|March 8, 2006
Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefitAlexander H Glassman, J Thomas Bigger, Michael Gaffney, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|June 29, 2002
Clinical management of cardiovascular risks during treatment with psychotropic drugsAlexander H Glassman
Dialogues in Clinical Neuroscience|May 18, 2007
Depression and cardiovascular comorbidityAlexander H Glassman
The Journal of Clinical Psychiatry|August 19, 2005
Schizophrenia, antipsychotic drugs, and cardiovascular diseaseAlexander H Glassman
Cleveland Clinic Journal of Medicine|July 13, 2010
The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raisedJ Thomas Bigger, Alexander H Glassman
Archives of General Psychiatry|September 9, 2009
Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participantsAlexander H Glassman, J Thomas Bigger, Michael Gaffney
The Journal of Clinical Psychiatry|March 16, 2005
Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarctionChristopher M O'Connor, Alexander H Glassman, David J Harrison
Archives of General Psychiatry|September 5, 2007
Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvementAlexander H Glassman, J Thomas Bigger, Michael Gaffney, et al.
The American Journal of Psychiatry|October 3, 2002
A randomized trial of sertraline as a cessation aid for smokers with a history of major depressionLirio S Covey, Alexander H Glassman, Fay Stetner, et al.
The Journal of Clinical Psychiatry|June 29, 2002
Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatmentHerbert Y Meltzer, Michael Davidson, Alexander H Glassman, et al.
Archives of General Psychiatry|March 8, 2006
Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefitAlexander H Glassman, J Thomas Bigger, Michael Gaffney, et al.
Pageof 2